Our newsroom provides you with the latest information about the German Breast Group. This section of the website also includes photographic material and information about our events. In addition, our Annual Scientific Reports, which provide an overview of our research activities, can be downloaded here.
In a paper in "The Breast" we discuss the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials.
GBG research at ESMO Breast Cancer Meeting 2022 May 3rd to 5th in Berlin.
ESMO has announced that the 2022 ESMO Breast Cancer Award is presented to Sibylle Loibl for her exceptional contribution to clinical research in breast cancer.
We are pleased to inform you that an exploratory analysis of the randomized phase III GrparOcto trial has been published in Cancer
We are happy to welcome you to the virtual GBG Annual meeting an March 9th to 11th 2022.
A biomarker analysis in luminal breast cancer using a humanized tumor mouse (HTM) model has been published in International Journal of Cancer.
We are happy to present our work at the San Antonio Breast Cancer Symposium , December 7-10
The survival analysis of the randomized phase III GeparOcto trial has been published in European Journal of Cancer
An analysis evaluating RAD51 test and its association with HRD and clinical outcome in primary TNBC from GeparSixto trial has been published in Annals of Oncology.
We are delighted to inform you that our results on the GAIN-2 trial has been published in European Journal of Cancer
We are happy to present our work at ESMO 2021, September 16-21th
We are delighted to inform you that our analysis on the utility of the CPS + EG score in triple-negative breast cancer patients has been published in European Journal of Cancer
We are pleased to inform you that a pooled analysis of patients with HER2-low-positive breast cancer has been published in The Lancet Oncology
A prospective analysis on chemotherapy-induced ovarian failure in young women with early breast cancer has been published in European Journal of Cancer
A pooled analysis on therapy response and prognosis of patients with low HR-positive, HER2-negative early breast cancer has been published in European Journal of Cancer
We are happy to inform you that results of several research projects from GBG and collaborative groups will be presented at the upcoming ASCO Annual Meeting 2021, which will take place from 4 to 8 June.
We are delighted to inform you that the first results of the randomized phase III PenelopeB trial have been published in Journal of Clinical Oncology.
An analysis including breast cancer patients with brain metastases from the BMBC registry has been published in Cancers
Registration for the ESMO Breast Cancer Virtual Meeting, taking place 5-8 May 2021 is now open.